<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ACS Omega &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/acs-omega/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 11 Oct 2026 07:19:34 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>ACS Omega &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Cancer Drug Candidates Show Dual Power Against Malaria Parasite</title>
		<link>https://bioengineer.org/cancer-drug-candidates-show-dual-power-against-malaria-parasite/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sun, 11 Oct 2026 07:19:34 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[ACS Omega]]></category>
		<category><![CDATA[anticancer compounds]]></category>
		<category><![CDATA[Drug repurposing]]></category>
		<category><![CDATA[drug resistance]]></category>
		<category><![CDATA[FAPESP]]></category>
		<category><![CDATA[gametocytes]]></category>
		<category><![CDATA[histone deacetylase]]></category>
		<category><![CDATA[malaria]]></category>
		<category><![CDATA[Plasmodium falciparum]]></category>
		<category><![CDATA[Plasmodium vivax]]></category>
		<category><![CDATA[rational drug design]]></category>
		<category><![CDATA[University of São Paulo]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=414183</guid>

					<description><![CDATA[University of São Paulo researchers found that fourteen derivatives of an anticancer compound kill Plasmodium falciparum at both the blood and gametocyte stages, pointing toward new antimalarial drugs designed around the parasite's histone deacetylase enzymes.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">414183</post-id>	</item>
	</channel>
</rss>
